跳至主要内容
临床试验/CTRI/2018/11/016319
CTRI/2018/11/016319已完成4 期

Health related cross-sectional drug utilization surveillance case control study on Home Nebulization in Bronchial asthma (HRAA study) - HRAA study

Glenmark Pharmaceuticals Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Adults with Moderate to Severe Br. asthma ie. poorly controlled receiving low or med-dose
  • ICS/LABA with history of Oral Steroid use or Hospitalization or Frequent use of rescue
  • medications for exacerbations

排除标准

  • Patients with < 1 follow up visit to be excluded from this Retrospective analyses
  • Smoking or Non-smoking Risk factors including exposure to Biomass or Occupational hazard
  • Patients on LTRAs &/or antihistamine combinations

研究者

发起方
Glenmark Pharmaceuticals Ltd

相似试验